Published in Clin Toxicol (Phila) on July 15, 2015
Re: External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose. Clin Toxicol (Phila) (2015) 1.07
Letter in response to: External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose. Clin Toxicol (Phila) (2015) 1.07
Letter in reply to Riggan et al. Re: External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose. Clin Toxicol (Phila) (2015) 0.75
Response to Letter to the Editor: External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose. Clin Toxicol (Phila) (2015) 0.75
Pharmacokinetic modelling of modified acetylcysteine infusion regimens used in the treatment of paracetamol poisoning. Eur J Clin Pharmacol (2017) 0.75
Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ (2009) 9.83
High risk clinical characteristics for subarachnoid haemorrhage in patients with acute headache: prospective cohort study. BMJ (2010) 4.65
Clinical decision rules to rule out subarachnoid hemorrhage for acute headache. JAMA (2013) 4.34
Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning. Ann Emerg Med (2009) 3.67
Collapse, reported seizure--and an unexpected pill. Lancet (2007) 3.25
Prospective validation of the ABCD2 score for patients in the emergency department with transient ischemic attack. CMAJ (2011) 2.45
Outbreak of fatal childhood lead poisoning related to artisanal gold mining in northwestern Nigeria, 2010. Environ Health Perspect (2011) 2.40
Pathogen inactivation: making decisions about new technologies. Report of a consensus conference. Transfusion (2007) 2.19
A prospective cohort study of patients with transient ischemic attack to identify high-risk clinical characteristics. Stroke (2013) 2.03
Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care. Ann Emerg Med (2009) 1.74
Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations. Clin Toxicol (Phila) (2014) 1.66
Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products. J Anal Toxicol (2010) 1.65
Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis. J Appl Physiol (1985) (2007) 1.62
Should spectrophotometry be used to identify xanthochromia in the cerebrospinal fluid of alert patients suspected of having subarachnoid hemorrhage? Stroke (2006) 1.61
Subdissociative-dose ketamine versus fentanyl for analgesia during propofol procedural sedation: a randomized clinical trial. Acad Emerg Med (2008) 1.57
Postpartum maternal codeine therapy and the risk of adverse neonatal outcomes: a retrospective cohort study. Clin Toxicol (Phila) (2012) 1.52
Case series of individuals with analytically confirmed acute mephedrone toxicity. Clin Toxicol (Phila) (2010) 1.47
Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol (2010) 1.46
Potential impact of N-terminal pro-BNP testing on the emergency department evaluation of acute dyspnea. CJEM (2006) 1.44
Gut decontamination of acutely poisoned patients: what do doctors really know about it? Emerg Med J (2007) 1.42
Availability of and use of Intralipid (lipid rescue therapy, lipid emulsion) in England and Wales. Emerg Med J (2010) 1.41
Management of body stuffers presenting to the emergency department. Eur J Emerg Med (2016) 1.40
Prescription opioid abuse in the UK. Br J Clin Pharmacol (2013) 1.31
Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J Cyst Fibros (2006) 1.30
The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). Drug Test Anal (2011) 1.24
2,4-dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death. J Med Toxicol (2011) 1.23
Effect of the UK's revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment. Br J Clin Pharmacol (2014) 1.22
Detection of the pharmaceutical agent glaucine as a recreational drug. Eur J Clin Pharmacol (2008) 1.11
The Global Educational Toxicology Uniting Project (GETUP): an Analysis of the First Year of a Novel Toxicology Education Project. J Med Toxicol (2015) 1.10
Methaemoglobinaemia associated with the use of cocaine and volatile nitrites as recreational drugs: a review. Br J Clin Pharmacol (2011) 1.09
Pragmatic interpretation of the study of nontraumatic subarachnoid hemorrhage in the setting of negative cranial computed tomography results: external validation of a clinical and imaging prediction rule. Ann Emerg Med (2013) 1.08
Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom: a review of the literature. Drug Saf (2007) 1.07
Limited evidence for the safety of β-blockers for cocaine-associated chest pain. Am J Emerg Med (2013) 1.07
Relapse after emergency department discharge for acute asthma. Acad Emerg Med (2008) 1.06
ICD-10 coding: poor identification of recreational drug presentations to a large emergency department. Emerg Med J (2010) 1.04
The EXTRIP (EXtracorporeal TReatments In Poisoning) workgroup: guideline methodology. Clin Toxicol (Phila) (2012) 1.02
Relative safety of hyperinsulinaemia/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observational study. Intensive Care Med (2007) 1.01
Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD). Drug Test Anal (2011) 1.01
Apical and basolateral localisation of GLUT2 transporters in human lung epithelial cells. Pflugers Arch (2008) 1.01
Putting cocaine use and cocaine-associated cardiac arrhythmias into epidemiological and clinical perspective. Br J Clin Pharmacol (2010) 1.01
When do the aminotransferases rise after acute acetaminophen overdose? Clin Toxicol (Phila) (2010) 0.99
Hyperglycaemia and pulmonary infection. Proc Nutr Soc (2006) 0.99
First case report of recreational use of 2,5-dimethoxy-4-chloroamphetamine confirmed by toxicological screening. Eur J Emerg Med (2008) 0.99
Prevalence of use and acute toxicity associated with the use of NBOMe drugs. Clin Toxicol (Phila) (2015) 0.99
Novel psychoactive substances: how to understand the acute toxicity associated with the use of these substances. Ther Drug Monit (2012) 0.98
Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis. J Cyst Fibros (2005) 0.96
Ethanol: tastes great! Fomepizole: less filling! Ann Emerg Med (2008) 0.96
An evaluation of the osmole gap as a screening test for toxic alcohol poisoning. BMC Emerg Med (2008) 0.95
Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology. Semin Dial (2014) 0.94
Mephedrone (4-methylmethcathinone): what is new in our understanding of its use and toxicity. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.94
Paracetamol toxicity: What would be the implications of a change in UK treatment guidelines? Eur J Clin Pharmacol (2012) 0.93
Management of cocaine-induced cardiac arrhythmias due to cardiac ion channel dysfunction. Clin Toxicol (Phila) (2009) 0.92
Do novel psychoactive substances displace established club drugs, supplement them or act as drugs of initiation? The relationship between mephedrone, ecstasy and cocaine. Eur Addict Res (2013) 0.92
Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur J Clin Pharmacol (2011) 0.91
Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP). Clin Toxicol (Phila) (2012) 0.90
Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP). J Med Toxicol (2008) 0.88
Epidemiology of recreational drug toxicity in a nightclub environment. Subst Use Misuse (2009) 0.88
The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'. Int J Drug Policy (2011) 0.88
First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201. Eur J Clin Pharmacol (2012) 0.87
Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments. Acad Emerg Med (2009) 0.87
Multidose activated charcoal for yellow oleander poisoning. Lancet (2003) 0.87
Multiple toxicity from 3,4-methylenedioxymethamphetamine ("ecstasy"). Am J Emerg Med (2003) 0.87
National audit of antidote stocking in acute hospitals in the UK. Emerg Med J (2012) 0.86
Alcohol hand rubs: hygiene and hazard. BMJ (2007) 0.85
Is cocaine use recognised as a risk factor for acute coronary syndrome by doctors in the UK? Postgrad Med J (2007) 0.85
Deliberate self-poisoning in Ontario following the terrorist attacks of September 11, 2001. JAMA (2005) 0.84
Incidence and management of N-acetylcysteine-related anaphylactoid reactions during the management of acute paracetamol overdose. Eur J Emerg Med (2014) 0.83
Patient knowledge of the paracetamol content of over-the-counter (OTC) analgesics, cough/cold remedies and prescription medications. Emerg Med J (2010) 0.83
Understanding lactic acidosis in paracetamol (acetaminophen) poisoning. Br J Clin Pharmacol (2011) 0.83
Pharmacokinetic effects of diphenhydramine or oxycodone in simulated acetaminophen overdose. Acad Emerg Med (2005) 0.83
Five-year trends in self-reported recreational drugs associated with presentation to a UK emergency department with suspected drug-related toxicity. Eur J Emerg Med (2013) 0.83
The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerg Health Threats J (2011) 0.82
Acute psychosis associated with recreational use of benzofuran 6-(2-aminopropyl)benzofuran (6-APB) and cannabis. J Med Toxicol (2013) 0.82